South Korea Biomaterials Market Size, Share, and COVID-19 Impact Analysis, By Product (Natural, Metallic, and Polymer), By Application (Cardiovascular, Orthopedics, and Plastic Surgery), and South Korea Biomaterials Market Industry Trend, Forecasts to 2035

South Korea Biomaterials Market Insights Forecasts to 2035

• The South Korea Biomaterials Market Size Was Estimated at USD 4076.4 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 18.87% from 2025 to 2035
• The South Korea Biomaterials Market Size is Expected to Reach USD 27292.6 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Biomaterials Market Size is Anticipated to Reach USD 27292.6 Million by 2035, Growing at a CAGR of 18.87% from 2025 to 2035. It is anticipated that the increasing prevalence of musculoskeletal and chronic skeletal disorders will boost demand for biomaterial-based implants, facilitating market growth.

Market Overview

The biomaterials market involves the development and use of natural, metallic, and polymer-based materials designed to interact with biological systems for medical purposes, such as implants, tissue engineering, and wound healing. Biomaterials offer benefits like biocompatibility, enhanced durability, and reduced risk of immune rejection, improving patient outcomes. Growing prevalence of chronic diseases and aging populations create significant market opportunities, especially in cardiovascular, orthopedic, and plastic surgery applications. In South Korea, government initiatives focused on advancing healthcare infrastructure, promoting biomedical research, and supporting regenerative medicine are driving market growth.

Report Coverage

This research report categorizes the market for South Korea biomaterials market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea biomaterials market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea biomaterials market.

Driving Factors

Advancements in medical technology, such as 3D bioprinting and nanotechnology, are enhancing the functionality and biocompatibility of biomaterials, expanding their applications in areas like tissue engineering and regenerative medicine. The rising prevalence of chronic diseases and an aging population are increasing the demand for medical implants and devices. Additionally, supportive government initiatives and increased investments in research and development are fostering innovation and accelerating the adoption of biomaterials across various healthcare settings.

Restraining Factors

A primary concern is the high cost associated with developing and manufacturing advanced biomaterials. The production of these materials often requires specialized equipment and raw materials, leading to elevated costs. For instance, biodegradable polymers and bioactive ceramics are expensive to produce, which can make biomaterial-based medical devices and implants significantly more costly than conventional options.

Market Segmentation

The South Korea biomaterials market share is classified into product and application.

• The natural segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea biomaterials market is segmented by product into natural, metallic, and polymer. Among these, the natural segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Its superior biocompatibility, reduced risk of immune rejection, and widespread use in tissue engineering and regenerative medicine. Materials like collagen, gelatin, and chitosan are increasingly favored for applications in wound healing and orthopedics.

• The cardiovascular segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea biomaterials market is segmented by application into cardiovascular, orthopedics, and plastic surgery. Among these, the cardiovascular segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. The rising prevalence of heart diseases and increasing demand for advanced implants like stents, heart valves, and vascular grafts. Innovations in biocompatible and durable biomaterials enhance the effectiveness and safety of cardiovascular treatments.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea biomaterials market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Samsung Biologics
• Celltrion
• LG Chem Life Sciences
• Seegene
• Medytox
• Genoss
• Kolon Life Science
• Hyundai Bioland
• Bioneer
• Hapla
• ISU Abxis
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea biomaterials market based on the below-mentioned segments:

South Korea Biomaterials Market, By Product

• Natural
• Metallic
• Polymer

South Korea Biomaterials Market, By Application

• Cardiovascular
• Orthopedics
• Plastic Surgery